Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats
- PMID: 15623566
- DOI: 10.1152/physiolgenomics.00226.2004
Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats
Abstract
Cardiac hypertrophy is a complex and nonhomogenous response to various stimuli. In this study, we used high-density oligonucleotide microarray to examine gene expression profiles during physiological hypertrophy, pathological hypertrophy, and heart failure in Dahl salt-sensitive rats. There were changes in 404/3,160 and 874/3,160 genes between physiological and pathological hypertrophy and the transition from hypertrophy to heart failure, respectively. There were increases in stress response genes (e.g., heat shock proteins) and inflammation-related genes (e.g., pancreatitis-associated protein and arachidonate 12-lipoxygenase) in pathological processes but not in physiological hypertrophy. Furthermore, atrial natriuretic factor and brain natriuretic protein showed distinctive changes that are very specific to different conditions. In addition, we used a resampling-based gene score-calculating method to define significantly altered gene clusters, based on Gene Ontology classification. It revealed significant alterations in genes involved in the apoptosis pathway during pathological hypertrophy, suggesting that the apoptosis pathway may play a role during the transition to heart failure. In addition, there were significant changes in glucose/insulin signaling, protein biosynthesis, and epidermal growth factor signaling during physiological hypertrophy but not during pathological hypertrophy.
Similar articles
-
Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-κB and MAPK signaling pathways.Free Radic Biol Med. 2015 May;82:1-12. doi: 10.1016/j.freeradbiomed.2015.01.005. Epub 2015 Jan 19. Free Radic Biol Med. 2015. PMID: 25614461
-
DNA microarray analysis of in vivo progression mechanism of heart failure.Biochem Biophys Res Commun. 2003 Aug 8;307(4):771-7. doi: 10.1016/s0006-291x(03)01252-x. Biochem Biophys Res Commun. 2003. PMID: 12878176
-
Gene expression profiling of exercise-induced cardiac hypertrophy in rats.Acta Physiol Scand. 2005 Dec;185(4):259-70. doi: 10.1111/j.1365-201X.2005.01494.x. Acta Physiol Scand. 2005. PMID: 16266368
-
Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.Clin Exp Pharmacol Physiol. 2007 Apr;34(4):255-62. doi: 10.1111/j.1440-1681.2007.04585.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17324134 Review.
-
Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies.Pharmacol Ther. 2010 Oct;128(1):191-227. doi: 10.1016/j.pharmthera.2010.04.005. Epub 2010 May 12. Pharmacol Ther. 2010. PMID: 20438756 Review.
Cited by
-
Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure.Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14471-6. doi: 10.1073/pnas.0602543103. Epub 2006 Sep 18. Proc Natl Acad Sci U S A. 2006. PMID: 16983087 Free PMC article.
-
Docosahexaenoic acid supplementation does not improve Western diet-induced cardiomyopathy in rats.PLoS One. 2012;7(12):e51994. doi: 10.1371/journal.pone.0051994. Epub 2012 Dec 26. PLoS One. 2012. PMID: 23300587 Free PMC article.
-
Distinct cardiac transcriptional profiles defining pregnancy and exercise.PLoS One. 2012;7(7):e42297. doi: 10.1371/journal.pone.0042297. Epub 2012 Jul 31. PLoS One. 2012. PMID: 22860109 Free PMC article.
-
Temporal regulation of expression of immediate early and second phase transcripts by endothelin-1 in cardiomyocytes.Genome Biol. 2008;9(2):R32. doi: 10.1186/gb-2008-9-2-r32. Epub 2008 Feb 14. Genome Biol. 2008. PMID: 18275597 Free PMC article.
-
Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance.PLoS One. 2019 Aug 30;14(8):e0221519. doi: 10.1371/journal.pone.0221519. eCollection 2019. PLoS One. 2019. PMID: 31469842 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical